Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
the aim of the study is to describe the management and outcome of patients having an osteo-articular infection treated by tedizolid as a suppressive antibiotic therapy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy | Other | description of osteo-articular infection managed with tedizolid as a suppressive antibiotic therapy |
| Measure | Description | Time Frame |
|---|---|---|
| rate of patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy | proportion of patients having tedizolid as a suppressive antibiotic therapy | between 2016 and 2021 |
| rate of failure in patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic | proportion of patients having a failure under tedizolid as a suppressive antibiotic therapy | 2 years |
| rate of adverse event in patients having had a BJI/PJI treated with tedizolid as a suppressive | proportion of patients having a adverse event under tedizolid as a suppressive antibiotic therapy | through study completion, an average of 1 year |
| Description of patients having had a BJI/PJI treated with tedizolid as a suppressive | type of patients: age, CMI, comorbidities... | 2 years |
| Description of BJI/PJI treated with tedizolid as a suppressive | implant or prothese or not, acute/ chronic, bacteriology | 2 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Not provided
patients having an osteo-articular infection treated with tedizolid as a suppressive antibiotic therapy managed at the CRIOAc LYON, Croix-Rousse Hospital
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospices Civils de Lyon | Lyon | 69004 | France |
Not provided
| Label | URL |
|---|---|
| Related Info | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C546016 | tedizolid |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided